LOXAPAC 50 mg/2 ml, solution injectable en ampoule (IM)
solution injectable
intramusculaire
Autorisation active
Procédure nationale
Commercialisée
8/6/1979
EISAI SAS
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!